Effects of demographics on the antihypertensive efficacy of triple therapy with amlodipine, valsartan, and hydrochlorothiazide for moderate to severe hypertension

By Calhoun David A.  

Current Medical Research and Opinion, Vol. 29, Iss. 8, 2013-08 ,pp. : 901-910

Informa Healthcare

Access to resources Recommend Favorite

Combination antihypertensive therapy with valsartan and hydrochlorothiazide in Chinese patients with mild-to-moderate hypertension

By Sun Ning-L.   Zhu Jun-R.   Zhao Yanxing   Tu Ying-M.    

Current Medical Research and Opinion, Vol. 24, Iss. 10, 2008-10 ,pp. : 2863-2871

Informa Healthcare

Access to resources Recommend Favorite

Telmisartan and hydrochlorothiazide combination therapy for the treatment of hypertension

By Kjeldsen Sverre E.   Schmieder Roland E.   Unger Thomas   Mancia Giuseppe  

Current Medical Research and Opinion, Vol. 26, Iss. 4, 2010-04 ,pp. : 879-887

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and tolerability of amlodipine/valsartan combination therapy in hypertensive patients not adequately controlled on valsartan monotherapy

By Sinkiewicz W.   Glazer R. D.   Kavoliuniene A.   Miglinas M.   Prak H.   Wernsing M.   Yen J.  

Current Medical Research and Opinion, Vol. 25, Iss. 2, 2009-02 ,pp. : 315-324

Informa Healthcare

Access to resources Recommend Favorite

Long-term safety, tolerability and efficacy of aliskiren in combination with valsartan in patients with hypertension: a 6-month interim analysis

By Chrysant Steven G.   Murray Alexander V.   Hoppe Uta C.   Dattani Dan   Patel Samir   Hsu Huang   Zhang Jack  

Current Medical Research and Opinion, Vol. 24, Iss. 4, 2008-04 ,pp. : 1039-1047

Informa Healthcare

Access to resources Recommend Favorite